KYLIE RAE JOINER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BYRON, GA NPI 1194438010

General Payments — all program years on this page

$306.52

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 16
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $293.56 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $293.5615

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $75.083
ABBVIE INC. $61.573
Lilly USA, LLC $41.793
Acerta Pharma LLC $39.862
UCB, Inc. $23.591
Novo Nordisk AS $22.651
Merck Sharp & Dohme Corporation $15.741
PFIZER INC. $13.281

By program year

Program yearAmountRecords
2023 $12.961
2024 $293.5615

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087123340 Novartis Pharmaceuticals Corporation $21.19 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087123342 Novartis Pharmaceuticals Corporation $21.86 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087123344 Novartis Pharmaceuticals Corporation $32.03 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100533157 Novo Nordisk Inc $22.65 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104340270 AstraZeneca Pharmaceuticals LP $16.56 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104416075 AstraZeneca Pharmaceuticals LP $23.30 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107416588 ABBVIE INC. $20.75 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107416590 ABBVIE INC. $21.93 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107416592 ABBVIE INC. $18.89 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132035122 PFIZER INC. $13.28 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135738482 Lilly USA, LLC $14.65 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135750535 Lilly USA, LLC $13.80 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135780580 Lilly USA, LLC $13.34 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141939541 Merck Sharp & Dohme LLC $15.74 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143052973 UCB, Inc. $23.59 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.